unknown
Stage
1
Investors
About
CellProthera is a clinical-stage biotechnology company developing a unique cell therapy for the regeneration of damaged heart tissue following acute myocardial infarction. Their lead product is currently in Phase I/IIb clinical trials.
Explore CellProthera's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.